Trending event

David Ferrera, a partner in Nutter’s Litigation Department and chair of the firm’s Product Liability practice group, will be a speaker at ACI’s Drug & Medical Device Litigation Conference. He will be a panelist on the “Navigating the New Rule 702 Amendments: Strategies for Expert Testimony in Drug and Medical Device Litigation” session. David will address how Rule 702’s landmark revision has transformed how expert testimony is assessed. Topics of discussion will include:

• Reviewing decisions in which courts have addressed, referenced, or relied upon the new rule
• Identifying what defense counsel can do to ensure that judges are actually implementing and applying the new Rule 702 changes going forward
• Examining the new rule clarification stating that the proponent of expert testimony has the burden of establishing all criteria by a preponderance of the evidence
• Evaluating the tighter connection between experts’ opinions and the methods they use – to eliminate experts who exaggerate the conclusions

ACI’s Drug and Medical Device Litigation conference has convened the greatest minds and leaders in the pharmaceutical and medical device industry for the last two decades. Designed for high-level strategy sharing and bringing together hundreds of industry leaders each year from in-house, private practice, and government, this is the only forum at which to gain essential winning life sciences product liability litigation strategies and anticipate what is next on the horizon.

Event details:
Wednesday, December 4, 2024
9:45AM ET

NY Marriott Marquis
1535 Broadway
New York, NY 10036